Request for Information - Advanced Ultrasound Capability (9-30-2025).docx

REQUEST FOR INFORMATION

1.0 RFI TITLE: Advanced Ultrasound Capability

2.0 AGENCY: The Defense Health Agency Operational Medical Systems

3.0 OFFICE: The Warfighter Expeditionary Medicine and Treatment Project Management Office

4.0 LOCATION: Fort Detrick, Maryland

5.0 SUBJECT: The Defense Health Agency’s (DHA) Operational Medical Systems (OPMED) Warfighter Expeditionary Medicine and Treatment Project Management Office (WEMT PMO) is conducting market research to determine whether a commercial solution or mature development effort can be provided to fulfill gaps in data management, communication, tracking patient data, more accurate triage and enhancing the abilities of less skilled medical professionals, fostering a more complete understanding of the casualty's condition and enhancing overall situational awareness, using an ultrasound solution.

6.0 DISCLAIMER: This is a Request For information (RFI) as defined in FAR 15.201(e) to ascertain whether a commercial item exists that provides the capabilities described herein. This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other types of offers will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. In keeping with the standards of FAR Part 10, the Government may request additional information from responders. Responders are solely responsible for all expenses associated with responding to this RFI or any follow-up information request. All information received in response to this RFI or any follow-up information request that is marked proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future request for proposal will not be entertained.

7.0 DESCRIPTION: DHA OPMED WEMT PMO has a near-term requirement to field an ultrasound solution with a U.S. Food and Drug Administration (FDA) indication for advanced portable capabilities to supplement diagnostic medical capabilities in far-forward environments (Role 1 to Role 3). The capability could feature advanced software capabilities including, but not limited to, Artificial Intelligence (AI) for image analysis, automated measurements, and decision support, or enhancing patient care through forward applications via streamlined data transfer to gather a holistic view of the patient. Alternatively, a novel hardware solution incorporating advanced software capabilities could address current limitations in portability, power consumption, durability, or imaging quality in challenging environments. The goal of this RFI is to canvas the research and market space for mature Technology Readiness Level 3 or above (TRL 3+). The WEMT PMO is interested in learning about products that are conducting or preparing to demonstrate safety and efficacy in a clinical population or already hold FDA clearances and approvals.

8.0 SUBMISSION INSTRUCTIONS: Responses from all capable and qualified sources are encouraged to respond to this request.

White papers should adhere to the following formatting and outline instructions:

1. All submissions shall be made electronically and be in one of the following formats: Microsoft Word or Adobe PDF.

2. Include a Cover Page (1page) with the following information:

· Title

· Organization

· Responders technical and administrative points of contact (names, addresses, phone, fax number and email addresses)

· Topic area(s) addressed

3. Complete Attachment 1 – Company and Product Information.

4. Complete Attachment 2 – Capability Characteristics. Please note that the response shall provide sufficient technical data to determine how your product fully meets the requirements detailed in Attachment 2 – Capability Characteristics.

9.0 SUBMISSION CONTACT INFORMATION: The point of contact for this action is Christopher Sult. Interested parties shall forward submissions to Christopher Sult at christopher.m.sult.civ@health.mil no later than 4:00PM EST on Oct 30, 2025. Only electronic responses are requested. Telephonic communication will not be considered as a submission nor receive a response. No evaluation letters and/or results will be issued to the respondents.

At this time, no solicitation exists; therefore, please do not request a copy of a solicitation. It is the responsibility of any potential offeror to monitor for the release of any possible solicitation or synopsis.